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Objective: To determine the usefulness of Eutectic Mixture of Local Anesthetic (EMLA)-
induced stimulated skin wrinkling (SSW) to detect diabetic sensorimotor polyneuropathy
(DSPN).
Research Design and Methods: Two hundred and ten diabetics were prospectively
recruited (mean age 58.5±12.7 years) from a large tertiary center from 2009 to 2011.
EMLA was applied to the tips of digits 2, 3, and 4 and the degree of wrinkling graded.
Diabetic Neuropathy Symptom (DNS) score, nerve conduction studies (NCS), Semmes–
Weinstein monofilament (SWMF) tests, and vibratory perception thresholds (VPTs) testing
were chosen as comparative clinical standards to diagnose length-dependent DSPN.
Results: Inter-rater agreement for two examiners of SSW was high, with Cohen’s weighted
κ of 0.912 for the right hand, and 0.823 for the left. K measure of agreement of SSW
with the NCS, DNS scores, SWMF testing, and VPT testing was 0.486, 0.243, 0.289, and
0.395 respectively. SSW was able to distinguish between normal and abnormal NCS and
DNS results, with median scores of 3.333 vs. 1.667 (p<0.0005); and 3.167 vs. 2.000
(p<0.0005) respectively. Following receiver operating characteristic-analysis, at a cut-off
point of <3 for an abnormal SSW test, sensitivity of SSW test for diagnosing DSPN using
NCS as a reference standard was 81.3%, and specificity was 67.0%, on par with other
testing methods.
Conclusion: SSW shows comparable sensitivity to other methods for detecting DSPN.
Given its low cost and easy administration, SSW can be considered a useful alternative
screening method for diagnosing diabetic neuropathy.
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INTRODUCTION
Stimulated skin wrinkling (SSW), refers to the reversible undu-
lations of the surface skin occurring 5–30 min following water
immersion or exposure to a eutectic mixture of local anesthetic
(EMLA) (1, 2). Skin wrinkling occurs as a result of vasoconstric-
tion in the glabrous skin, mediated by post-ganglionic sympathetic
fibers (2). As a test, it can be a simple method of determining
small nerve fiber function (1, 3), and has been shown to correlate
with intraepidermal nerve fiber density (IENFD) in patients with
a sensory neuropathy (4, 5).
Of the neuropathies developing in diabetic patients, the most
common form is a chronic, symmetrical, length-dependent dia-
betic sensorimotor polyneuropathy (DSPN) (6). There is overall
agreement that small nerve fiber involvement occurs earlier than
large fiber neuropathy, is common and may even be subclinical
(7). Screening for early diabetic polyneuropathy is essential for
timely foot care to prevent foot ulcers. At present, abnormal nerve
conduction studies (NCS) is advocated as a minimal criteria for
the diagnosis of DSPN (8). However, NCS generally requires the
consultation of a trained neurologist and/or technologist, and the
use of specialized electrodiagnostic equipment, which are often
not readily available especially in a general practice setting. NCS
also only assesses larger nerve fiber function. Alternative screening
methods for diabetic distal polyneuropathy have been developed
and used, such as clinical scoring systems (9, 10), including the
Diabetic Neuropathy Symptom (DNS) score (11), the Semmes–
Weinstein monofilament (SWMF), vibration threshold testing
(12), and autonomic tests (13). However, many of these meth-
ods have not been well-validated, and may be time-consuming, or
require their own specialized equipment.
We sought to determine if SSW with EMLA could be used as
a simple diagnostic tool for diabetic neuropathy, especially since
small nerve fibers are affected early on in the course of diabetic
polyneuropathy (14).
RESEARCH DESIGN AND METHODS
Diabetic patients, aged 21–80 years were prospectively and con-
secutively recruited from specialist diabetic and neurology clinics
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in a tertiary center (National University Hospital, Singapore) over
a 2-year period from 2009 to 2011. Patients were recruited based
on a confirmed diagnosis of diabetes mellitus and the persons
recruiting were not aware of the presence or absence of diabetic
polyneuropathy. The institutional review board of the hospital
approved the study.
PATIENTS
After giving informed consent, 210 diabetic patients were
recruited. Patients had to fulfill criteria for the diagnosis of Dia-
betes Mellitus (15). Patients subsequently underwent a detailed
medical and neurological evaluation to exclude other discernible
causes of large- or small-fiber neuropathy. Exclusion criteria were
a history or laboratory evidence of uremia, cancer, past or current
chemotherapy, alcohol abuse, solvent or toxic exposure, demen-
tia, spinal cord and root disease, thyroid dysfunction, vitamin B12
deficiency, and presence of peripheral vascular disease or abnor-
mal vascular responses such as Raynaud’s phenomenon. Patients
with open wounds over the finger-tips where the EMLA cream
would be applied were also excluded.
TESTS OF NERVE FUNCTION
Nerve conduction studies, the DNS score, SWMF test, and Vibra-
tory Perception Threshold (VPT) testing using Biothesiometry
were chosen as our comparative clinical standards for SSW. All
tests were performed using standardized protocols on the same
day for each patient. The DNS score was obtained first, followed
by the SWMF and VPT tests, then the NCS. The SSW was per-
formed in between these tests depending on the availability of the
testing room. Two technicians with more than 5 years of experi-
ence and board certification performed all the tests blinded to the
clinical status of the patient.
DNS SCORE
The score has the following items: (i) unsteadiness in walking, (ii)
pain, burning or aching at legs, or feet, (iii) prickling sensations
in legs or feet, and (iv) numbness in legs or feet. It is scored “1” if
a symptom occurred several times a week during the last 2 weeks,
and scored as absent “0” if it did not, with the maximum score
being 4 points. As per guidelines, diabetic polyneuropathy was
scored present with 1–4 points, and absent with 0 points (11).
SEMMES–WEINSTEIN MONOFILAMENTS
These were tested using the five-piece hand kit on the plantar
aspect of the hallux, and the base of the first, third, and fifth
metatarsals (with removal of callus when necessary), using stan-
dard guidelines (16, 17). Monofilament testing was also conducted
on the palmar aspect of the index finger, middle finger, and ring
finger. The patient was asked to say “yes” when he or she sensed
the application of a monofilament. Three trials were administered
for filaments 2.83 (0.07 g) and 3.61 (0.4 g). When the patient was
unable to respond correctly in at least one trial, a heavier monofil-
ament (4.31, 4.56, 6.65) was trialed only once (2, 4, and 300 g
monofilaments respectively). As per manufacturer, insensitivity
to 0.4 g monofilament and lighter was taken as abnormal plan-
tar thresholds. Peripheral polyneuropathy was diagnosed when
plantar thresholds of both feet were abnormal.
VIBRATION PERCEPTION THRESHOLD TESTING
Vibratory perception threshold was tested using a hand-held Bio-
thesiometer (Biomedical Instruments, Newbury, OH, USA) per-
formed according to standardized protocols (18, 19). The device
was held with the rubber tactor placed perpendicular to the pulp
of the terminal phalanx of the thumb, over the pulp of the big
toe, and over the medial malleoli. The voltage of vibration was
gradually increased from 0 V until the patient could perceive the
vibration. This was performed three times, and the mean of the
three trials taken to determine the VPT. Age-adjusted reference
values were used, with abnormal values considered as at least 2
SDs higher than the mean (19, 20). For a VPT test to be consid-
ered indicative of diabetic polyneuropathy, patients had to have
abnormal readings over both big toes.
NERVE CONDUCTION STUDIES
Nerve conduction studies testing studied the median, ulnar, per-
oneal, tibial, and sural nerves of all four limbs. Skin temper-
ature was recorded, and NCS recordings made using a two-
channel electromyography machine (Medelec Synergy, Oxford
Instruments, Oxford, UK), following suggested standardized nerve
conduction study protocols, according to the standards of the
American Association for Neuromuscular and Electrodiagnostic
Medicine (21).
Parameters evaluated included the distal motor latency (dML),
compound muscle action potential (CMAP), amplitude measured
from the baseline to the negative peak, mean F-wave latency, distal
sensory latency (dSL) measured to the negative peak, and sensory
nerve action potential (SNAP) amplitude measured from nega-
tive to positive peak. Using standardized distances between elec-
trode placements, conduction velocity (CV) was also calculated.
Antidromic testing was carried out for sural nerve testing, while
orthodromic testing was performed for median sensory and ulnar
sensory testing. An age-standardized normal range determined in
our local population was used. Patients were diagnosed with dia-
betic polyneuropathy when an abnormal sural nerve (dSL and/or
SNAP) response was obtained, with an abnormal peroneal (CMAP
and/or F-wave) response. Both sural nerves had to be abnormal to
meet the case definition of diabetic polyneuropathy (22).
In addition, patients were also evaluated for presence of median
neuropathy at the wrist, with additional testing of a second
lumbrical-interossei (2L-INT) latency difference. Neurophysio-
logical results were taken as supportive of median neuropathy at
the wrist in the case of two of the three following abnormalities:
median nerve motor distal latency>4.4 ms, median nerve sensory
distal latency >3.4 ms or absent, and a 2L-INT latency difference
>0.6 ms (based on our own laboratory norms).
STIMULATED SKIN WRINKLING TEST
One milliliter of EMLA (lidocaine 2.5% and prilocaine 2.5%,
AstraZeneca), or the amount needed to thickly and completely
cover the distal digit pulp, was applied evenly onto the finger-
tips of the index finger, middle finger, and ring finger (digit 2, 3,
and 4) of both hands. This was covered with Tegaderm® tape for
30 min. Photographic documentation pre-EMLA and post-EMLA
was performed. Wrinkling was graded using a previously pub-
lished scale and was based on the assessment of the photographic
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picture obtained (Figure 1) (4). Previously, we had established
that skin wrinkling in response to EMLA in normal subjects was
grade 3 and 4 (1) (skin wrinkling was therefore considered abnor-
mal if absent or severely impaired; Grades 0–2). The grading of
wrinkles were: Grade 0, wrinkling absent; Grade 1, just percepti-
ble wrinkling, with the fingertip not completely smooth; Grade 2,
two or less lines of superficial wrinkling on the fingertip; Grade 3,
three or more lines of deep wrinkling on the fingertip; Grade 4,
wrinkling completely distorts the pulp of the fingertip. Wrinkling
grades for digits 2, 3, and 4 were totaled and averaged. A differ-
ence of ≥3 marks per hand (i.e.,≥1 mark per digit) was taken as
cut-off for a different score. A score of ≥9 marks for each hand
was taken as normal and without evidence of neuropathy. Patients
were not allowed to apply any hand cream in the 1-h preceding
testing. SSW evaluation was performed blinded as the assessment
was performed without the knowledge of the other results.
In order to assess test reproducibility, two trained examiners
blinded to the patient’s clinical status, graded the skin wrinkling
scores in 46 of these patients, both on the same day of testing,
under identical conditions.
The following data variables was also collected: current smok-
ing history, presence of hypertension, recent ingestion of coffee or
tea within the preceding 3 h of the SSW test, and skin temperature.
STATISTICAL ANALYSIS
All statistical analyses were performed using SPSS-PC statistical
software (version 20.0). Student’s t -tests were used to compare
continuous data between patients with normal and abnormal
SSW tests, while Fisher’s exact test performed for categorical data.
p Values <0.05 were considered significant. Receiver Operating
Characteristic (ROC) curve analysis was used to determine the
operating characteristics of the various clinical methods tested on
the identification of patients with diabetic polyneuropathy, using
NCS criteria as the reference standard. Inter-rater agreement was
assessed using Cohen’s weighted κ. Unless stated, hands and feet
were analyzed as a pair.
RESULTS
Two hundred and ten diabetic patients were recruited. Fourteen
patients had missing data for DNS scores, one had missing data
for SSW, one had missing data for NCS, and two had missing data
for VPT. Patient characteristics are summarized in Table 1.
REPRODUCIBILITY
We have previously demonstrated a high inter- and intra-rater cor-
relation for the SSW assessment with EMLA (5). In this current
study, 2 trained examiners blinded to the patient’s clinical status,
graded the skin wrinkling scores in 46 of these patients, both on
the same day of testing, under identical conditions. Inter-rater
agreement showed a Cohen’s weighted κ for both raters of 0.912
for the right hand, and 0.823 for the left hand, indicating a good
level of agreement.
RELATIONSHIP OF SSWWITH THE TESTS OF NERVE FUNCTION
K measure of agreement between SSW test and the studied tests of
nerve function was calculated. SSW test had best agreement with
NCS compared to the other screening methods. Agreement scores
FIGURE 1 |Wrinkling scale.
Table 1 | Patient characteristics.
Age (years) 58.5±12.7 (21–80)
Males 41.4
Duration of DM (years) 7.33±6.54 (1–33)
Diabetes type (Type 1/Type 2) 8.22/91.78
HbA1c 8.36±1.93 (5.6–13.6)
Presence of retinopathy 12.0
Presence of nephropathy 40.0
Abnormal NCS consistent with DSPN 53.6
Abnormal DNS scores 67.3
Abnormal SWMF tests consistent with DSPN 28.1
Abnormal VPT testing consistent with DSPN 72.1
Abnormal SSW scores 58.9
Data are in percentage, or means±SD (ranges).
with the NCS, DNS scores, SWMF testing, and VPT threshold
testing were 0.486, 0.243, 0.289, and 0.395 respectively.
RELATIONSHIP OF SSWWITH NCS AND DNS AS REFERENCE
STANDARDS
Stimulated skin wrinkling was able to predict the presence of
abnormal NCS or DNS results, with a median SSW score of 3.333
vs. 1.667 for normal (n= 97) and abnormal NCS (n= 112) respec-
tively (p< 0.0005); and a median SSW score of 3.167 vs. 2.000 for
normal (n= 64) and abnormal DNS score (n= 132) respectively
(p< 0.0005). Figure 2 shows the relationship of SSW with other
nerve tests.
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FIGURE 2 | Comparison of stimulated skin wrinkling with other test
parameters.
SENSITIVITY AND SPECIFICITY USING NCS AS THE REFERENCE
STANDARD
Figure 3 shows the ROC curves of the clinical tests of nerve func-
tion, when compared with NCS. The areas under the curve for
SWMF testing, VPT testing, and DNS scores were 0.760, 0.798,
and 0.735 respectively. Area under the curve for SSW test was
0.732, comparable to that of DNS scoring.
At a cut-off point of <3 as an abnormal SSW test, using NCS
as the reference standard, sensitivity of SSW test for diagnosing
DSPN was 81.3%, and specificity was 67.0%. This put SSW on par
with VPT testing, with the highest sensitivity and specificity of the
clinical tests studied.
VARIABLES ASSOCIATED WITH STIMULATED SKIN WRINKLING TEST
Of the variables studied, an abnormal SSW test was associated with
older ages and lower skin temperatures (Table 2).
DISCUSSION
This large study of diabetic patients is the first to demonstrate
that SSW is a valid and reliable tool for detecting the presence of
diabetic neuropathy. The strength and novelty of this research are
the prospective nature and large size of the sample and the use
of multiple standardized validated comparators of nerve function
(NCS, VPT, SWMF, and DNS).
Diagnosing diabetic neuropathy can be challenging as differ-
ent nerve fiber populations are not evenly affected. There is an
emerging consensus that small nerve fibers are earliest and most
consistently affected in a length-dependent fashion (14, 23, 24).
This suggests that methods based on detecting small-fiber neu-
ropathy may be particularly promising in testing for diabetic distal
symmetric polyneuropathy (7).
Stimulated skin wrinkling has been studied as a simple method
of small nerve fiber function, and used to detect autonomic neu-
ropathy in diabetics and leprosy (25, 26). It has been shown to
predict abnormal IENFD in patients with sensory neuropathy (4,
FIGURE 3 | ROC of various test parameters.






Mean age (years) 54.80±13.77 60.26±11.31 0.003
Mean temperature (°C) 31.94±1.70 31.34±2.01 0.025
Males 47 (39.8) 71 (60.2) 0.673
Current smoking 10 (38.5) 16 (61.5) 0.833
Hypertension 56 (40.3) 83 (59.7) 0.767
Coffee/tea intake in preceding 3 h 14 (60.9) 9 (39.1) 0.071
Presence of median neuropathy
at the right wrist
26 (32.5) 43 (37.4) 0.544
Presence of median neuropathy
at the left wrist
27 (31.8) 35 (31.2) 1.000
Data are means±SD or n (%).
5), an accepted end-point for clinical trials for early stages of dia-
betic neuropathy (27). Based on this knowledge, our study sought
to determine the use of SSW as a cost-effective, simple diagnostic
tool for distal diabetic neuropathy.
Where previous studies had used clinical examination (7), or
foot ulceration (28) as clinical end-points to test various screening
methods, we chose NCS criteria as our reference standard. This
was to give us an unequivocal cohort of distal polyneuropathy,
since mimicking conditions can result in up to 30% of patients
with similar clinical characteristics (29). Clinical examination, on
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the other hand, is limited even in the best examiners (30). Foot
ulceration as a clinical end-point is not infrequently confounded
by the presence of peripheral vascular disease or musculoskeletal
foot deformities. NCS remains the most objective and commonly
used method of evaluating polyneuropathy in research trials (31,
32). Nerve CV has also been suggested as the best predictor of foot
ulceration, when in comparison to the other tests of the sensory
modalities, including perception threshold testing of vibration,
temperature, and pressure (33).
Our results validate our previous findings of using the cut-
off point of <3 as an abnormal SSW test when in comparison to
NCS-determined DSPN (1). Using this cut-off, SSW was of at least
equivalent sensitivity and specificity in determining the presence
of DSPN as that of VPT testing with a hand-held Biothesiome-
ter, which was found to have the best sensitivity and specificity
in comparison to the other studied methods of testing for DSPN
based on ROC-analysis. Our study also showed that SSW test is
dichotomizes between normal and abnormal NCS findings and
normal and abnormal DNS scores.
Nerve conduction studies, while the most sensitive and spe-
cific method for detecting diabetic polyneuropathy (12), have the
problem of requiring trained technologists and/or neurologists
with expensive equipment to perform and interpret the studies.
Furthermore, NCS do not identify small nerve fiber damage, an
important component of diabetic neuropathy.
Alternative, more commonly used, screening methods include
light touch testing via monofilament, or vibratory sensation test-
ing via a hand-held biothesiometer or tuning fork (34). These
tests, however, again are restricted in their assessment of mainly
large fiber function, with limited value in cases of early neu-
ropathy, other neurological comorbidities, and in the elderly (12,
35, 36). In addition, these screening methods have been rarely
compared to NCS findings, but rather to predict foot ulceration
(28). Despite being more readily administered than NCS, these
tests still require some training and the purchase of specialized
equipment.
Clinical scoring systems, despite being advocated as a pos-
sible way to assess both large and small-fiber dysfunction, are
limited in their need for patient cooperation, and can be time-
consuming and tedious to administer. IENFD as a screening test
for small-fiber dysfunction in diabetes cannot be used as a screen-
ing tool due to its invasiveness and need for high-level expertise
in obtaining and interpreting the sample. Other available tests to
evaluate small-fiber function include pain perception (Neurotip),
qualitative temperature perception (Tiptherm rod), thermal per-
ception threshold (TPT) testing, and sudomotor function tests,
as well as more novel methods including NeuroQuick and Neu-
ropad. Again, many of these tests involve expensive equipment and
trained personnel, and lack rigorous validation (7). More recently,
ultrasonography of the posterior tibial nerve has been studied as
a screening method for DSPN (37). Other than requiring trained
sonographers, and the need to purchase an ultrasound machine,
sonography demonstrated a lower sensitivity than SSW testing (69
vs. 81.3%).
Eutectic mixture of local anesthetic-induced SSW testing has
a theoretical advantage of being able to screen for both early
and late diabetic neuropathy based on the concept of small
nerve fiber dysfunction being affected early. In out study we
were not able to confidently categorize patients recruited into
early of late neuropathy and so were not able to test this theory.
EMLA-induced SSW testing is easy to perform, inexpensive, and
requires no specialized equipment except tubes of EMLA cream
and sticky tape. EMLA-induced SSW is based on water-immersion
skin wrinkling, and tests sympathetic nerve fibers which regu-
late digit pulp vasoconstriction (2). In addition, the skin response
to EMLA follows a more linear response than water wrinkling,
and persists for over 90 min, allowing sufficient time for grad-
ing of the wrinkling by the observer (2). As both our results
presented here and earlier studies have shown, SSW demon-
strates good repeatability, and can be achieved with minimal
training (1).
Papanas and Ziegler proposed that an ideal test for diabetic
neuropathy should fulfill the following criteria: (a) high sensitivity,
specificity, and reproducibility; (b) be easy to use; (c) contribute
to early diagnosis of neuropathy; and (d) be cost-effective (7).
In this, SSW fulfills the criteria of being reproducible, easy to
use, cost-effectiveness, and potentially the ability to detect early
diabetic neuropathy. While the sensitivity of SSW is fairly high,
specificity is somewhat lower suggesting that it may be best used
as a screening tool for diabetic neuropathy.
Our work is limited by not correlating the use of SSW with the
clinical end-point of foot ulceration and amputation. However,
foot ulceration also results from the contributory factors of periph-
eral vascular disease that may confound skin wrinkling, while NCS
is an objective marker of neuropathy. Our patient cohort also con-
sists of mainly type two diabetic patients. This is not surprising,
given our adult cohort of patients and a minority of patients hav-
ing Type 1 Diabetes. A further issue decreasing the sensitivity and
specificity of SSW is that it is performed over the fingers and not
over the toes, the latter harboring the longer axons, and repre-
senting the maximum of diabetic length-dependent neuropathy.
However skin wrinkling of the toes has yet to be translated into
a repeatable useful test of small nerve fiber function and needs to
overcome the considerable technical difficulties of performing this
test on the toes.
Patients with more natural skin wrinkling, e.g., the elderly, may
also make interpretation of the final wrinkling grade difficult. We
had previously found that this can be circumvented by comparing
the area of stimulated wrinkling with that of the adjacent control
skin in order to counter over-scoring (5). Our study validates this
as a reasonable method of grading skin wrinkling, given we found
that the elderly were more likely to have abnormal wrinkling scores,
correlating with the finding of age as an independent predictor of
IENFD in healthy individuals (38). Further improvement of speci-
ficity may result if pre-existing wrinkling is subtracted from the
final wrinkling score.
In this study, we also sought to look for other possible con-
founders affecting skin wrinkling, such as median neuropathy at
the wrist, given that involvement of peripheral vasomotor fibers
has been reported in carpal tunnel syndrome (39). More recently,
in a smaller sample of 32 hands, carpal tunnel syndrome has been
shown to result in reduced vasoconstriction (and hence skin wrin-
kling) over digits 3 and 4 (40). Our study, however, could not
confirm this as a confounder.

























































Ping Ng et al. Skin wrinkling for detecting neuropathy
To further enable the use of SSW in the screening for DSPN,
studies should be performed on the relation of SSW to resultant
amputation or foot ulcers. Furthermore, SSW in patients with
impaired glucose tolerance may be useful since as a test, SSW
could be particularly useful in subclinical diabetic neuropathy,
where NCS does not detect abnormality.
In summary, our study suggests that SSW can be used as a
diagnostic tool for diabetic neuropathy. Its advantages are low
cost, simple administration, and easy reproducibility with minimal
training. It may have a particular role in the cognitively impaired
and other patients who are unable to tolerate NCS, or cooper-
ate with questionnaires or monofilament and threshold testing.
With comparable sensitivity to other diagnostic methods, SSW
can be considered especially in the general practice setting, sim-
ilar to urine dipstick testing for renal dysfunction, and retinal
photography for eye damage.
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